Over the past four years, 84% of the biologics approved for therapeutic use were produced using mammalian cells. Despite its popularity, cell line development is one of the most time-consuming processes in biomanufacturing.
High-throughput, automated solutions significantly reduce the time spent on intricate protocols, while also increasing productivity, efficiency and reliability.Download this listicle to learn more about how you can use automation to:
- Minimize bottlenecks
- Improve yield
- Reduce costs